908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
908 Devices reported Q2 2026 revenue of $16.1 million, up 23% year-over-year, driven by strong demand for its VipIR product and the addition of NIRLab revenue. The company raised its full-year 2026 revenue guidance to $68.0 million to $70.0 million, representing 21% to 25% growth, while narrowing its Adjusted EBITDA loss by more than 50% to $1.9 million.
Key figures
- Revenue
- 16100000
- Guidance
- 2026 revenue $68.0 million to $70.0 million (from $67.0 million to $70.0 million)
- Revenue Yoy
- 23%
- Gross margin
- 52%
- Cash position
- 101500000
- Installed base
- 4101
- Protectir order
- 6000000
- Recurring revenue
- 4900000
- Adjusted gross margin
- 57%
- Vipir units shipped q2
- 35
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.